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Abstract Purpose Pelvic organ prolapse (POP) is a major health issue worldwide, affecting 6–
8% of women. The most affected site is the anterior vaginal wall. Multiple procedures
and surgical techniques have been used, with or without the use of vaginal meshes, due
to common treatment failure, reoperations, and complication rates in some studies.
Methods Systematic review of the literature and meta-analysis regarding the use of
vaginal mesh in anterior vaginal wall prolapse was performed. A total of 115 papers
were retrieved after using the medical subject headings (MESH) terms: ‘anterior pelvic
organ prolapse OR cystocele AND surgery AND (mesh or colporrhaphy)’ in the PubMed
database. Exclusion criteria were: follow-up shorter than 1 year, use of biological or
absorbable meshes, and inclusion of other vaginal wall prolapses. Studies were put in a
data chart by two independent editors; results found in at least two studies were
grouped for analysis.
Results After the review of the titles by two independent editors, 70 studies were
discarded, and after abstract assessment, 18 trials were eligible for full text screening.
For final screening and meta-analysis, after applying the Jadad score (> 2), 12 studies
were included. Objective cure was greater in the mesh surgery group (odds ratio
[OR] ¼ 1,28 [1,07–1,53]), which also had greater blood loss (mean deviation [MD]
¼ 45,98 [9,72–82,25]), longer surgery time (MD ¼ 15,08 [0,48–29,67]), but less
prolapse recurrence (OR ¼ 0,22 [01,3–0,38]). Dyspareunia, symptom resolution and
reoperation rates were not statistically different between groups. Quality of life (QOL)
assessment through the pelvic organ prolapse/urinary incontinence sexual question-
naire (PISQ-12), the pelvic floor distress inventory (PFDI-20), the pelvic floor impact
questionnaire (PFIQ-7), and the perceived quality of life scale (PQOL) was not
significantly different.
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Introduction
Pelvic organ prolapse (POP) is a major health issue world-
wide, and even nowadays it represents a great challenge to
modern gynecology.1–3 In epidemiologic surveys, “vaginal
bulge” sensation reaches up to 6–8% of all female interview-
ees; and if pelvic examination alone is considered, the
numbers rise to 30–60% of all women.4,5 POP diagnosis
goes back to Antiquity, andmultiple treatments and theories
have been tried and abandoned over the years, with frequent
recurrence and uncertain success rates.3
The anterior vaginal wall is the most commonly affected,
being responsible for up to 80% of all POP surgical proce-
dures.2 The possible reasons for this dominance lie on its
anatomical characteristics, in that the anterior vaginal wall
lies on a more horizontal position in the female pelvis,
suffering further gravitational pressure, without having
any muscle support; moreover, the tissue separating the
anterior vaginal wall from the bladder is comparatively
thinner and more distensible than that enfolding the other
vaginal walls.2,4
Several surgical techniques have arisen and been dis-
charged over the years.3 High recurrence rates and compli-
cations in POP surgery led to the development of meshes for
the anterior vaginal wall since the 1950’s – from biological
meshes, autologous (fascia) and heterologous (porcine), to
synthetic ones, both absorbable and non-absorbable, with
conflicting results and alarming complication rates in some
series.1,3,5
Recent studies revealed that synthetic meshes seem
superior to biological ones, and both produce better
anatomical outcomes when compared with simple col-
phorraphy – however, with higher complication rates,
such as larger intraoperative bleeding, slower surgical
time and greater extrusion rates, and apparently without
significant differences in the quality of life questionnaire
assessment, although long follow-up studies on this issue
are rare.
The main goal of this meta-analysis is to evaluate the
effectiveness of POP surgery and its complications, empha-
sizing the anterior vaginal wall, with and without mesh use.
Conclusions Anterior vaginal prolapse mesh surgery has greater anatomic cure rates
and less recurrence, although there were no differences regarding subjective cure,
reoperation rates and quality of life. Furthermore, mesh surgery was associated with
longer surgical time and greater blood loss. Mesh use should be individualized,
considering prior history and risk factors for recurrence.
Resumo Introdução Prolapso de órgãos pélvicos é problema de saúde públicas, sendo o mais
comum o anterior. Para tratamento são utilizadas cirurgias, com ou sem telas. O uso de
telas é para diminuir recidivas, mas não h
á consenso.
Métodos Foi realizada revisão da literatura e metanálise, sobre uso de telas na
correção do prolapso anterior. Base de dados foi PUBMED , com termos (MESH):
“Anterior Pelvic Organ OR Cystocele AND Surgery AND (Mesh or Colporrhaphy)”.
Critérios de exclusão foram: seguimento menor que 1 ano, telas biológicas ou
absorvíveis. Resultados: foram avaliados 115 artigos. Após revisão dos títulos, 70
estudos foram descartados e 18 após leitura de resumos. Após critérios de Jadad (>2),
12 estudos foram incluídos. Análise estatística foi razão de risco ou diferença entre
médias dos grupos, e as análises com grande heterogeneidade foram avaliadas através
de análise de efeito aleatório.
Resultados Cura objetiva foi superior no grupo com tela - OR 1,28 (1,07-1,53, p 
0,00001), maior perda sanguínea - diferença média (MD) 45,98 (9,72-82,25, p = 0,01),
tempo cirúrgico mais longo - MD 15,08 (0,48-29,67, p = 0,04), porém menor
recorrência - OR 0,22 (0,13-0,38, p = 0,00001), não apresentando maior resolução
dos sintomas - OR 1,93 (0,83-4,51, p = 0,15). Dispareunia e taxa de reoperação também
não foram diferentes entre grupos. Qualidade de vida não apresentou diferença.
Conclusões Cirurgia com tela para prolapso vaginal anterior apresenta melhor taxa
de cura anatômica e menor recorrência, sem diferenças cura subjetiva, reoperação e
qualidade de vida. Há maior tempo cirúrgico e perda sanguínea. Uso de telas deve ser
individualizado.
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Methods
A systematic reviewandmeta-analysiswas conducted on the
effectiveness and complications regarding women treated
for anterior vaginalwall prolapse surgically, comparingmesh
treatment with traditional surgery.
For a complete original article search, the following steps
were covered, according to the preferred reporting items for
systematic reviews and meta-analyses (PRISMA)6 statement
– search in the PubMed database with the medical subject
headings (MESH) terms: ‘anterior pelvic organ prolapse OR
cystocele AND surgery AND (mesh or colporrhaphy)’.
Inclusion criteria: Randomized controlled trials, in En-
glish, published in the past 15 years, including only women
with anterior vaginal wall prolapse, comparing surgical
treatment without mesh versus using synthetic absorbable
meshes.
A total of 115 articles, after filtering results by species
(human), gender (female) and language (English), were
recovered. The last online search was performed on
June 20th, 2015. After excluding duplicate series, identified
by abstract reading, a total of 109 articles were included for
final screening. The inclusion process was performed by two
independent reviewers (EBC, and LCS).
Exclusion criteria were the following: articles regarding
other vaginal walls or incontinence as a main result; follow-
up shorter than one year; anatomic evaluationmadewithout
the use of the pelvic organ prolapse quantification (POP-Q)7
rating; literature or systematic reviews; studies using bio-
logical or absorbable meshes; and uncontrolled/non ran-
domized trials.
Initially, the articles were selected by their titles/ab-
stracts; afterwards, full text articles that potentially met
all the inclusion criteria were assessed. Whenever there was
lack of accordance between the two reviewers, a third
researcher was consulted (CRTJ). After this initial screening,
included articles were submitted to Jadad8 criteria, and only
papers for which the Jadad score was greater than 2 were
finally included.
In the papers where the inclusion criteria were met,
assessed data were: objective cure; surgery time; intra-
operative blood loss; recurrence rate; reoperation rate (for
surgical failure); “vaginal bulge” complaint resolution rate;
dyspareunia; and subjective cure through quality of life
questionnaires –pelvic organ prolapse/urinary incontinence
sexual questionnaire (PISQ-12);9 pelvic floor distress inven-
tory (PFDI-20);10 pelvic floor impact questionnaire (PFIQ-
7);10 and perceived quality of life scale (P-QOL ).11
Outcomes verified in more than two articles were
grouped for meta-analysis. A chart for data collection was
created to extract the data of interest in each article, which
were then retyped to a single database by two independent
researchers, to avoid loss of data or mistyping of any kind.
The bias risk was assessed by the use of a Cochrane Collabo-
ration tool.12
The statistical analysis for outcomes measured in propor-
tion (dichotomous) used the Mantel-Haenszel test, assessing
the risk ratio between the groups. The statistical analysis for
quantitative outcomes (with averages and standard devia-
tions) assessed the mean difference between the groups.
The heterogeneity between studies was assessed through
Chi-square test of study homogeneity and through the I2
index, which varies from 0–100%, where: 0–40%: there is no
significant heterogeneity; 30–60%: there may be moderate
heterogeneity; 50–90%: there may be substantial heteroge-
neity; 75–100%: there is plenty of heterogeneity between
studies.
For studies with heterogeneity superior to 50% and
p < 0.05, a random effect meta-analysis was performed.13
The computer system utilized was the Review Manager 5.3
(IKMD, Copenhagen, Denmark).12
Results
Search strategy crossing the terms “Anterior pelvic organ
prolapse OR cystocele AND surgery AND (mesh or colpor-
rhaphy)” was conducted in the PubMed online database. A
total of 115 articles were retrieved, which came down to 109
after the exclusion of repeated series through title/abstract
analysis. Afterwards, 70 articles were discarded by the title
due to failure to meet the inclusion criteria.
Two independent reviewers assessed the 39 remaining
abstracts, and finally 18 papers were included for eligibility
analysis. After full article evaluation, another 4 articles were
excluded, with 14 remaining to be submitted to Jadad8 score
assessment. Two more articles were excluded for Jadad
scores under 3, with 12 articles included for final analysis
(►Fig. 1 and ►Table 1).
Objective Cure
For objective cure analysis, all 12 articles were included
(1,540 women), with 86% heterogeneity (p < 0.00001). Pa-
tients in the mesh surgery group were considered cured in
551/781 cases, whereas 418/759womenwere found cured in
the surgery without mesh group, with 1.28 (confidence
interval, CI ¼ 1.07–1.53) greater objective cure risk in the
group submitted tomesh surgery, after aleatory effect meta-
analysis (►Fig. 2).
Surgery Duration
For the analysis of surgery duration, 5 articles were included
(779 women), with great heterogeneity. After aleatory effect
meta-analysis, the group of women submitted to surgery
without mesh was found to have less surgical time, with mid
difference of 15.08 minutes (CI ¼ 0.48–29.67).
Blood Loss
For blood loss assessment, 3 articles were included (631
women), with substantial heterogeneity. After aleatory ef-
fect analysis, the mesh surgery group was found to have
greater blood loss, with a mean difference of 45.98 ml (CI
¼ 9.72–82.25).
Prolapse Recurrence
Five articles were included for recurrence rate analysis (585
women), without significant heterogeneity among them. The
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Fig. 1 Articles inclusion criteria or pelvic organ prolapse surgery and its complications.
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Table 1 Articles that evaluated effectiveness of Pelvic Organ Prolapse surgery and its complications
Articles N Mesh Follow-up Objective cure
(POP-Q)
QOL Subjective cure Complications Complication
rates
Conclusion
Altman et al14 410 Prolift 1 year S < 2 þ UDI
(question 16)
60.8  34.5%
UDI
PISQ-12
“asymptomatic”
75.4  62.1%
UDI-5
24.2  17.7
UDI-0
8.7  12.3
PISQ-12
Duration
52.6  33.5 minute
Blood loss
84.7  35.4 mL
Bladder perforation
7  1
Pain 5  0
Retention
16  6
Cystoscopy
11  1
Extrusion
3.2%
Greater short time
success. with great-
er complications
de Tayrac et al15 163 Ugytex 1 year S < 2
89  64%
PFDI
PFIQ
PISQ-12
MHU
PFDI (question 5)
31.3 52.2
PISQ-12
28.5  30.3
“satisfied”
96  92%
Dyspareunia
20  27.3%
Hospital stay
4.3  4.7 days
Abnormal bleeding
1  3
Pain
28  15%
Extrusion
9.5%
Greater anatomic
success. with slight
increase in compli-
cation rates
Delroy et al16 79 Nazca TC 1 year S < 2
82.5  56.4%
P-QOL General improvement
(not significant)
Duration
99.1  46 minutes
Hospital stay
3.2  3.3 days
Abnormal bleeding
45  30.8%
Dyspareunia
5  10.2%
Extrusion
5.0%
Anatomical im-
provement with
equivalent compli-
cations and QOL
El-Nazer et al17 40 Gynemesh 2 years S < 2
95  70%
PFMS (perineal strength)
P-QOL “bulge” resolution
94.7  68.4%
“Voiding dysfunction”
resolution
93.3  66.7%
Duration
75  76 minutes
Hospital stay
2.6  2.6 days
Blood loss
215.5  219.5 mL
Bladder perforation: 0
Extrusion
5%
Recurrence
5  15%
Anatomical and
functional
improvement
Gutman et al18 65 Prolift 3 years S < 2
45  43%
PFDI
PFIQ
PGI-I
PISQ-12
“bulge” resolution
92  81%
“feels better”
88  81%
Dyspareunia
2  1
Extrusion
15%
Reoperation
13  0%
Non significant ana-
tomical and subjec-
tive improvement in
both groups
Hiltunen et al19 202 Parietene
(manufact.)
1 year S < 2
93.3  61.5%
“symptoms” “bulge” resolution
93  94%
Voiding dysfunction
9  8%
De novo incontinence
23  10%
Duration
73  58 minutes
Blood loss
190  114 mL
Bladder perforation1  0
Urinary retention
13  5
Extrusion
17.3%
Recurrence
(symptomatic)
4  15%
Anatomical im-
provement with re-
currence reduction
and bigger inconti-
nence rates
Lamblin et al20 68 Perigree 2 years S < 2
100  84.4%
PFDI-20
PFIQ-7
POP-QOL
VAS
“sexuality”
PFIQ-7
28  23
PFID-20
49  40
Duration
69.7  74.6 minute
Hospital stay
4.4  4.6 days
Abnormal bleeding
0  3%
Retention
0  5.8%
Extrusion
6%
Recurrence
0  11.7%
Greater anatomic
results with equiva-
lent QOL and slight-
ly greater morbidity
Nguyen et al21 76 Perigree 2 years S < 2
89  55%
PFDI-20
PFIQ-7
PISQ-12
PFDI-20
34þ 31  45þ -32
PFIQ-7
14þ 23  23þ -31
PISQ-12
34  33
Hemoglobin drop
2.4  1.8
Dyspareunia
9  16%
Extrusion
5%
Recurrence
0  3%
Better anatomical
results (best for pa-
tients with high risk
for recurrence)
Nieminen et al22 202 Parietene
(manufactured)
3 years S < 2
91  65%
Non
validated score
Score “bulge”
1.16  1.43
De novo incontinence
7  5%
Extrusion
19%
Recurrence
13  41%
Reoperation
11  18%
Better anatomical
results with equiva-
lent symptom reso-
lution. but high
extrusion
Sivaslioglu et al23 90 Parietene 1 year S < 2
91  72%
P-QOL P-QOL
6.2þ -5.5 
7.5þ -6.2
Dyspareunia
4.6  0%
De novo incontinence
0  7%
Extrusion
6.9%
Failure
9.3  28.5%
Better anatomical
results
Tamanini et al24 100 Naxca TC 1 year S < 2
83.7  55.5%
ICIQ-VS QOL and sexuality Dyspareunia
2.3  0%
bleeding (< 500 mL)
2.3  1.8%
Extrusion
9.3%
Better anatomical
results without QOL
difference
Vollebregt et al25 125 Avaulta 1 year S < 2
91  41%
UDI
IIQ
QOL equivalent
(asymptomatic
recurrences)
Dyspareunia
15  9%
Blood loss 77  69 mL
Hospital stay 3  3 days
Extrusion 4%
Reoperation
0  5%
Better anatomical
results. without sig-
nificant QOL
difference
Abbreviations: ICIQ-VS, international consultation of incoherencemodular questionnaire vaginal symptoms; IIQ, incontinence impact questionnaire;
MHU, urinary dysfunction measurement scale PGI-I, patient global impression of improvement; S, stage; UDI, urogenital distress inventory; PFDI,
pelvic floor distress inventory, PFDI-20, 20 questions; PFIQ, pelvic floor impact questionnaire; PFIQ-7, seven questions; PFMS, pressure and fluid
management symptoms; PISQ-12, pelvic organ prolapse/ urinary incontinence sexual questionnaire; POP-Q, pelvic organ prolapse quantification;
QOL, quality of life; UDI, urogenital distress inventory; UDI-0, obstructive discomfort; UDI-5, irritative symptoms; UDI-S, stress symptoms;
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mesh surgery group had 19 recurrences in 300 patients,
while the group without mesh had 62 cases in 285 women –
the mesh group had less recurrence: OR ¼ 0.22 (CI ¼ 0.13–
0.38) (►Fig. 3).
Prolapse Related Reoperation
Three articles were considered for this analysis, totaling 357
women. Mesh surgery patients were reoperated 15/183
cases, whereas in the group without mesh, 21/174 patients
had new surgical POP related procedures, with no significant
difference between groups: OR ¼ 0.65 (CI ¼ 0.83–4.51)
(►Fig. 4).
Subjective cure
For the analysis of subjective cure rates, considering
“vaginal bulge” symptom resolution, 3 articles were selected
(282 women). The mesh surgery group had vaginal bulge
resolution in 135/144 patients, whereas 122/138 women in
the group without mesh reported bulge resolution, without
statistical difference: OR ¼ 0.65 (CI ¼ 0.83–1.29).
Dyspareunia
For dyspareunia rate evaluation, 6 articles were included
(397women), without significant heterogeneity. In themesh
group, dyspareunia was found in 15/193 patients, while it
was found in 16/204 women in the group without mesh,
showing no statistical difference: OR ¼ 0.94 (CI ¼ 0.45–
1.96).
Quality of life validated questionnaires (►Fig. 5)
For sexual function analysis, through the PISQ-12 ques-
tionnaire, 3 articles were enrolled, with a total of 612
women. The mean difference between groups was -0.38
(from -3.12 to 2.37), without statistical significance.
The subjective assessment through the P-QOL question-
naire included 2 articles, with 164 women. There was no
significant heterogeneity among studies. The results showed
no statistical difference in quality of life after surgerywith or
without mesh, with amean difference of -0.94 (from -3.31 to
1.42).
The PFIQ-7 quality of life questionnaire evaluation includ-
ed 2 articles, totaling 137 women. There was no significant
difference between groups, with a mean difference of -0.77
(from -14.25 to 12.74) after aleatory effect analysis.
Finally, the PFDI-20 questionnairewas analyzed including
2 articles (139 women), also without statistical difference
between groups, with amean difference of 0.20 (from -19.95
to 19.66) after aleatory effect analysis.
Discussion
This meta-analysis showed that the use of meshes for the
treatment of anterior vaginal wall prolapse is superior to
native tissue surgical repair, when objective cure through
POP-Q assessment is considered.14–25 All of the articles
included in this meta-analysis considered as an objective
cure criterion a post-surgical POP-Q stage inferior to 2 in the
pelvic examination. This definition of cure, that is, when the
prolapse’s maximum extent stays at least 1 cm above the
hymenal ring, is based on the recommendations of the US
National Institute of Health (NIH) workshop.26
However, this POP-Q based cure assessment has been
criticized by many authors – many discrete or moderate
prolapses are not classified using this criterion as cure or
Fig. 2 Objective cure rates after surgery with and without vaginal
mesh.
Fig. 4 Reoperation rate in surgery for POP with and without vaginal
mesh.
Fig. 3 Recurrence rate in surgery for POP with and without vaginal
mesh.
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absence of prolapse, although they have no impact on
women’s quality of life and, therefore, demand no
intervention.27,28
For the prolapse patient, the main goal is symptom relief
and quality of life improvement; accordingly, quality of life
assessment in these cases seems more trustworthy than the
POP-Q classification alone.
There are several different ways to assess quality of life,
with the use of subjective criteria or validated question-
naires. This meta-analysis showed no significant results
when evaluating the “vaginal bulge” symptom resolution,
with no statistical difference between the groups with or
without the use of mesh; but an aleatory effect analysis had
to be made due to the great heterogeneity among studies.
Aleatory effect meta-analysis adds variance to the general
effect proportionally to the variability of the results in the
studies; thatmakes the confidence intervals of the estimated
summary measure be bigger than those of the fixed effect
meta-analysis.
When we evaluated quality of life using 4 different
validated questionnaires (PISQ-12, P-QOL, PFIQ-7 and
PFDI-20), we observed no significant difference in quality
of life rating betweenwomen submitted to prolapse surgery
with or without mesh use. A previous Cochrane Meta-
analysis also concluded that although anterior vaginal
mesh placement shows better anatomical results, it does
not promote better functional outcomes.5
Furthermore, our study showed that women submitted to
mesh surgery have lower prolapse recurrence rates (80%
less), without heterogeneity among analyzed articles, which
increases this result’s credibility. The risk of a woman having
to go through surgery for pelvic prolapse during her entire
life is  6–19%, with 30% chance of a new intervention for
recurrence of the prolapse.29,30
Moreover, reoperation rates after reconstructive pro-
lapse surgery are very high (43–58%),31,32 which led to
the use of synthetic meshes in the last decades, in an
attempt to lower those flawed outcomes. This meta-analy-
sis shows that the use of vaginal meshes is effective in
diminishing recurrence rates; nevertheless, with increased
surgery duration and blood loss, which may increase pro-
cedure-related morbidity.
The use of vaginal meshes is not free of risk. The main
complications are: vaginal mesh erosion; infection; granulo-
mas; dyspareunia; vesicovaginal fistula; and chronic pelvic
pain. In 2008, the American Food and Drug Administration
(FDA) released its first notification about the complications
associated to the use of synthetic meshes, after receiving
more than one thousand complication reports. In 2011, the
FDA released two more statements about indications and
security concerning mesh use.33
This meta-analysis revealed a 7,4% medium rate of mesh
erosion (3.2–19%). Mesh erosion or exposure rate varies with
follow-up time, being observed from 6 weeks up to 7 years
after the surgical procedure. Studies included in this meta-
analysis had at least 1 year of follow-up; however, this may
be considered a short time for this particular evaluation,
explaining the low rate of extrusion observed.
Therefore, albeit the benefit of less prolapse recurrence,
mesh surgery should be evaluated carefully, given the fact of
morbidity elevation (longer surgeries and greater blood loss)
and related extrusion rates. Furthermore, there was no
difference in reoperation rates comparing mesh versus no
mesh surgery – the most probable explanation for this fact is
that maybe recurrence did not affect substantially those
women’s quality of life to the point that a new surgical
approach was needed.
There was no significant difference in de novo dyspareu-
nia rates betweenmesh and no-mesh groups. Dyspareunia is,
as stated above, one of the main complications associated
with the use of vaginal meshes, and is a very important
aspect to be considered in women with prolapse, especially
those whowish to maintain a sexual healthy sexual life after
surgery, being directly related to patient satisfaction and
quality of life. This meta-analysis also showed that there was
no statistical difference in quality of sexual life in women
with and without mesh, evaluated through the PISQ-12
questionnaire. The fact that women submitted to mesh
surgery did not showgreater dyspareunia rates or significant
mesh erosion in our report may have contributed to this
sexual life equality between groups.
Fig. 5 Quality of life after POP surgery with or without mesh.
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Conclusions
Female genital prolapses are a great cause of quality of life
prejudice, with sexual, psychological and functional (defeca-
tion and micturition) impairment.4,5 Costs related to female
POP surgery are high and growing worldwide. A 46% rise in
corrective pelvic surgeries is expected in the next decades,
due mainly to population aging.34,35
The choice of an effective and safe treatment for genital
prolapse is really important, and another fact to be taken into
consideration, especially in the anterior vaginal wall defects,
is that they are frequently associated with defects of the
vaginal apex. Women with anterior vaginal stage 3 (POP-Q)
prolapses have up to 98% chance of having a concomitant
uterus/vault prolapse of at least the first stage36 – this
association and its correction were not taken into consider-
ation in many studies assessed in this meta-analysis.
Despite many strong points, such as inclusion of only
randomized controlled trials of the past 15 years with
minimum follow-up of 1 year, and with paper quality ad-
dressed by Jadad criteria, this meta-analysis has some lim-
itations, mainly because of study heterogeneity, great
difference in quality of life evaluation among studies, short
follow-up for the appearance of certain late complications,
such asmesh extrusion and recurrence, and the lackof a clear
apex evaluation/treatment in the trials.
Future studies with longer follow-up and inclusion of an
apex thorough evaluation and concomitant treatment when
operating the anterior vaginal wall are necessary to better
enlighten the definitive role of vaginal meshes in this
scenario.
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